InsidersTradesSigma
Follow the 康美药业 share price and the full directors' dealings record of the company, a publicly traded company based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 康美药业 has recorded 1 insider filings. Market capitalisation: €18.7bn. The latest transaction was filed on 14 February 2022 (Sale). Among the most active insiders: 李建华. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
康美药业 is a Chinese company specializing in the pharmaceutical and healthcare industry. It is listed on the Shanghai Stock Exchange (XSHG).